078140 — Daebongls Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Daebongls Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,395	10,042	11,794	6,182	9,687
Depreciation
Amortisation
Non-Cash Items	1,473	786	-3,048	-2,963	-1,420
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	4,240	-3,667	-3,084	-728	2,677
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	15,702	10,099	8,776	5,889	14,339
Capital Expenditures	-8,676	-6,421	-5,674	-9,586	-26,489
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-46,814	-9,695	-16,104	7,353	-4,089
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-55,490	-16,116	-21,779	-2,233	-30,577
Financing Cash Flow Items	15,675	0	—	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	38,164	2,147	14,044	3,343	20,136
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,718	-3,869	1,041	7,002	3,933